Drug intelligence / Profile preview

propenidazole

Development stage
Unknown
Modality
Small Molecules
Administration
Oral (inferred From Class; Specific Routes For This Drug Not Explicitly Stated), Vaginal (inferred From Atc Code G01AF14 For Gynecological Use)
01

Overview

Propenidazole is a synthetic small molecule belonging to the nitroimidazole class of compounds. It is structurally related to other nitroimidazoles such as metronidazole and functions primarily as an anti-infective and antiprotozoal agent. Propenidazole acts by damaging microbial DNA through reduction of its nitro group under anaerobic conditions, leading to cell death. It has been investigated for use in gynecological infections and protozoal diseases but remains experimental with a maximum clinical trial phase of II[1][2][8]. Its primary indications are within the genitourinary system as a gynecological anti-infective and antiseptic[1][8].

Brand names
propenidazole
Other names
propenidazolpropenidazole [INN]
02

Targets

Neuraminidase

Beyond the preview

Go deeper on propenidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on propenidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call